Myrbetriq and Roxicodone drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Myrbetriq (mirabegron) and Roxicodone (oxycodone hydrochloride). Common drug interactions include fatigue among females and dizziness among males.

The phase IV clinical study analyzes what interactions people have when they take Myrbetriq and Roxicodone. It is created by eHealthMe based on reports of 23 people who take the same drugs from the FDA, and is updated regularly.

What is Myrbetriq?

Myrbetriq has active ingredients of mirabegron. It is often used in urge incontinence. eHealthMe is studying from 33,658 Myrbetriq users. Check the latest studies of Myrbetriq.

What is Roxicodone?

Roxicodone has active ingredients of oxycodone hydrochloride. It is often used in pain. eHealthMe is studying from 20,099 Roxicodone users. Check the latest studies of Roxicodone.



On Jul, 04, 2026

23 people who take Myrbetriq and Roxicodone together, and have interactions are studied.

Myrbetriq and Roxicodone drug interactions.

What are the common drug interactions of Myrbetriq and Roxicodone, by gender? *:

female:

  1. Fatigue (feeling of tiredness)
  2. Muscle spasms (muscle contraction)
  3. Muscular weakness (muscle weakness)
  4. Joint range of motion decreased (disease of joint movement)
  5. Muscle spasticity (tight or stiff muscles and an inability to control those muscles)
  6. Neuralgia (pain in one or more nerves)
  7. Pyrexia (fever)
  8. Chills (felling of cold)
  9. Cough
  10. Decreased appetite

male:

  1. Dizziness
  2. Benign neoplasm of bladder (benign (non-cancerous) tumours of the bladder)
  3. Mobility decreased (ability to move is reduced)
  4. Oxygen saturation decreased
  5. Peripheral vascular disorder
  6. Skin ulcer
  7. Surgery
  8. Thrombocytopenia (decrease of platelets in blood)
  9. Vomiting
  10. Weight decreased

What are the common drug interactions of Myrbetriq and Roxicodone, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Obesity (having too much body fat)
  2. Allergy to metals
  3. Drug hypersensitivity
  4. Seasonal allergy (allergic condition due to certain season)
  5. Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)
  6. Cerebrovascular disorder (disease of brain)
  7. Pulmonary embolism (blockage of the main artery of the lung)

50-59:

  1. Pyrexia (fever)
  2. Tumour lysis syndrome (a group of metabolic complications that can occur after treatment of cancer, these complications are caused by the breakdown products of dying cancer cells)

60+:

  1. Fatigue (feeling of tiredness)
  2. Muscle spasms (muscle contraction)
  3. Dysphagia (a condition in which swallowing is difficult or painful)
  4. Dysphonia (speech disorder attributable to a disorder of phonation)
  5. Dyspnoea exertional (breathlessness or shortness of breath)
  6. Fall
  7. Gait disturbance
  8. Headache (pain in head)
  9. Hyperglycaemia (high blood sugar)
  10. Hypokalaemia (low potassium)

What are the existing conditions these people have? *

  1. Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 8 people, 34.78%
  2. Insomnia (sleeplessness): 8 people, 34.78%
  3. Rickets (softening of bones): 7 people, 30.43%
  4. Muscle Spasticity (tight or stiff muscles and an inability to control those muscles): 7 people, 30.43%
  5. Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 6 people, 26.09%
  6. Cataplexy (loss of muscle tone accompanied by full conscious awareness): 6 people, 26.09%
  7. Migraine (headache): 3 people, 13.04%
  8. Parkinson's Disease: 2 people, 8.70%
  9. Nausea (feeling of having an urge to vomit): 2 people, 8.70%
  10. Hypertonic Bladder (bladder-storage function that causes a sudden urge to urinate): 2 people, 8.70%

* Approximation only. Some reports may have incomplete information.

Do you take Myrbetriq and Roxicodone?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Myrbetriq and Roxicodone:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Myrbetriq:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Roxicodone:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Myrbetriq and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Roxicodone and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on mirabegron and oxycodone hydrochloride (the active ingredients of Myrbetriq and Roxicodone, respectively), and Myrbetriq and Roxicodone (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: